CRISPR/Cas9-mediated gene manipulation to create single-amino-acid-substituted and floxed mice with a cloning-free method

被引:0
|
作者
Xiaolong Ma
Chao Chen
Jennifer Veevers
XinMin Zhou
Robert S. Ross
Wei Feng
Ju Chen
机构
[1] The Second Xiangya Hospital,Department of Cardiothoracic Surgery
[2] Central South University,Department of Medicine
[3] University of California San Diego,Cardiology
[4] Veterans Administration Healthcare San Diego,undefined
来源
Scientific Reports | / 7卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Clustered regulatory interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) technology is a powerful tool to manipulate the genome with extraordinary simplicity and speed. To generate genetically modified animals, CRISPR/Cas9-mediated genome editing is typically accomplished by microinjection of a mixture of Cas9 DNA/mRNA and single-guide RNA (sgRNA) into zygotes. However, sgRNAs used for this approach require manipulation via molecular cloning as well as in vitro transcription. Beyond these complexities, most mutants obtained with this traditional approach are genetically mosaic, yielding several types of cells with different genetic mutations. Recently, a growing body of studies has utilized commercially available Cas9 protein together with sgRNA and a targeting construct to introduce desired mutations. Here, we report a cloning-free method to target the mouse genome by pronuclear injection of a commercial Cas9 protein:crRNA:tracrRNA:single-strand oligodeoxynucleotide (ssODN) complex into mouse zygotes. As illustration of this method, we report the successful generation of global gene-knockout, single-amino-acid-substituted, as well as floxed mice that can be used for conditional gene-targeting. These models were produced with high efficiency to generate non-mosaic mutant mice with a high germline transmission rate.
引用
收藏
相关论文
共 50 条
  • [21] Employing pH-responsive RNA triplex to control CRISPR/Cas9-mediated gene manipulation in mammalian cells
    Yan Liu
    Yang Wang
    Jiayi Zhu
    Xuxian Su
    Xudong Lin
    Liang Xu
    Xiwen Xing
    Chinese Chemical Letters, 2024, 35 (09) : 245 - 248
  • [22] Fludarabine increases nuclease-free AAV- and CRISPR/Cas9-mediated homologous recombination in mice
    Shinnosuke Tsuji
    Calvin J. Stephens
    Giulia Bortolussi
    Feijie Zhang
    Gabriele Baj
    Hagoon Jang
    Gustavo de Alencastro
    Andrés F. Muro
    Katja Pekrun
    Mark A. Kay
    Nature Biotechnology, 2022, 40 : 1285 - 1294
  • [23] Fludarabine increases nuclease-free AAV- and CRISPR/Cas9-mediated homologous recombination in mice
    Tsuji, Shinnosuke
    Stephens, Calvin J.
    Bortolussi, Giulia
    Zhang, Feijie
    Baj, Gabriele
    Jang, Hagoon
    de Alencastro, Gustavo
    Muro, Andres F.
    Pekrun, Katja
    Kay, Mark A.
    NATURE BIOTECHNOLOGY, 2022, 40 (08) : 1285 - +
  • [24] Delineating the functions of RIPK1 in vivo through CRISPR/Cas9-mediated gene editing in mice
    Zhang, Xuhua
    Dowling, John P.
    Zhang, Jianke
    JOURNAL OF IMMUNOLOGY, 2019, 202 (01):
  • [25] Generation of prolactin-inducible protein (Pip) knockout mice by CRISPR/Cas9-mediated gene engineering
    Terceiro, Lucas E. L.
    Blanchard, Anne A. A.
    Edechi, Chidalu A.
    Freznosa, Agnes
    Triggs-Raine, Barbara
    Leygue, Etienne
    Myal, Yvonne
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2022, 100 (01) : 86 - 91
  • [26] CRISPR/Cas9-Mediated In Vivo Gene Targeting Corrects OTC Deficiency in the Newborn OTC spfash Mice
    Wang, Lili
    Yang, Yang
    Breton, Camilo Ayala
    Bell, Peter
    Li, Mingyao
    Zhang, Jia
    Saveliev, Alexei
    He, Zhenning
    White, John
    Xu, Chenyu
    Yu, Hongwei
    McMenamin, Deirdre
    Morizono, Hiroki
    Batshaw, Mark L.
    Wilson, James M.
    MOLECULAR THERAPY, 2017, 25 (05) : 236 - 237
  • [27] CRISPR/Cas9-Mediated In Vivo Gene Targeting Corrects Hemostasis in Newborn and Adult Hemophilia B Mice
    Wang, Lili
    Yang, Yang
    Breton, Camilo Ayala
    Bell, Peter
    White, John
    Li, Mingyao
    Zhang, Jia
    Saveliev, Alexei
    McMenamin, Deirdre
    Wilson, James M.
    MOLECULAR THERAPY, 2017, 25 (05) : 295 - 295
  • [28] Effect of single guide nucleotide mismatch in CRISPR/Cas9-mediated disruption of the human rhodopsin gene in vitro
    Peddle, Caroline
    McClements, Michelle E.
    MacLaren, Robert E.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [29] Crispr/Cas9-Mediated In Vivo Gene Targeting Corrects Haemostasis in Newborn and Adult FIX-KO Mice
    Wang, Lili
    Yang, Yang
    White, John
    Deirdre, McMenamin
    Bell, Peter
    Wilson, James M.
    BLOOD, 2016, 128 (22)
  • [30] CRISPR/Cas9-mediated genome editing induces gene knockdown by altering the pre-mRNA splicing in mice
    Tang, Ji-Xin
    Chen, Dafeng
    Deng, Shou-Long
    Li, Jian
    Li, Yuanyuan
    Fu, Zheng
    Wang, Xiu-Xia
    Zhang, Yan
    Chen, Su-Ren
    Liu, Yi-Xun
    BMC BIOTECHNOLOGY, 2018, 18